Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 25

Trial Status

Completed7

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT00015028Phase 2Completed
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00015041Phase 1Completed
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
Opioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00015067Phase 1Completed
Cocaine-Methylphendidate Interaction Study - 4
Cocaine-Related Disorders
Principalinvestigator
NCT00015080Phase 2Completed
Naltrexone in Treatment of Cocaine Dependence - 5
Cocaine-Related Disorders
Principalinvestigator
NCT00015132Phase 2Completed
Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9
Cocaine-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Moderately Similar
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Moderately Similar
9 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related DisordersOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Frederick Altice, MD

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00015028Phase 2PrincipalInvestigator

Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00015041Phase 1PrincipalInvestigator

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Opioid-Related DisordersSubstance-Related Disorders
Completed
NCT00015054Phase 2PrincipalInvestigator

Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3

Cocaine-Related Disorders
Completed
NCT00015067Phase 1PrincipalInvestigator

Cocaine-Methylphendidate Interaction Study - 4

Cocaine-Related Disorders
Completed
NCT00015080Phase 2PrincipalInvestigator

Naltrexone in Treatment of Cocaine Dependence - 5

Cocaine-Related Disorders
Completed
NCT00015106Phase 2PrincipalInvestigator

Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7

Cocaine-Related Disorders
Completed
NCT00015132Phase 2PrincipalInvestigator

Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9

Cocaine-Related Disorders
Completed

All 7 trials loaded